Drug resistance rates of Mycobacterium tuberculosis at a private referral center in Korea

31Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

The goals of this study were to identify first-line drug resistance in new and previously treated tuberculosis (TB) cases and to determine risk factors for multidrug-resistant TB (MDR-TB) at a private referral center in Korea. All patients with culture-confirmed pulmonary TB over a 2-yr period between July 2002 and June 2004 were prospectively included in this study. In total, 637 patients were included; 512 (80.4%) were new cases, and 125 (19.6%) were previously treated cases. Resistance to at least one first-line drug was identified in 11.7% of new cases and 41.6% of previously treated cases. MDR-TB was detected in 3.9% of new cases and 27.2% of previously treated cases. The proportion of extensively drug-resistant TB among MDR-TB patients was 16.7% (9/54). Factors associated with MDR-TB included age under 45 yr, previous TB treatment, and the presence of cavitation on chest radiography. Rates of first-line drug resistance are high, particularly in previously treated patients, in the private sector in Korea. This underscores the need for an improved control program, coupled with early diagnosis of MDR-TB, to reduce the spread and development of resistance. Copyright © The Korean Academy of Medical Sciences.

Cite

CITATION STYLE

APA

Jae, C. C., Song, Y. L., Gee, Y. S., Man, P. C., Kim, H., On, J. K., … Koh, W. J. (2007). Drug resistance rates of Mycobacterium tuberculosis at a private referral center in Korea. Journal of Korean Medical Science, 22(4), 677–681. https://doi.org/10.3346/jkms.2007.22.4.677

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free